94749 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen atoms
Alpha, Beta-UNSATURATED AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#2D3 DOPAMINE RECEPTOR-SELECTIVE NEGATIVE ALLOSTERIC MODULATORS
#3MONOMERS CONTAINING A 4-THIAZOLIDINONE UNIT AND THEIR POLYAMIDE, POLYESTER AND POLYURETHANE POLYCONDENSATES
#4SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
#5N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR
#6HYDROGEN PEROXIDE-RESPONSIVE KEAP1-NRF2 PPI INHIBITOR PRODRUG, AND PREPARATION METHOD THEREFOR
#7Reduction of the odor of monothiocarbonate compounds by addition of oxidants
#8ESTERS OF NON- AROMATIC HETEROCYCLIC COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF
#9SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
#10Substituted N-acetyl-L-cysteine derivatives and related compounds
#11Process for the preparation of kinase inhibitors and intermediates thereof
#12Method for Producing Alpha-substituted Cysteine or Salt Thereof or Synthetic Intermediate of Alpha-substituted Cysteine
#13Thiazolidinone compounds and use thereof
#14Substituted N-acetyl-L-cysteine derivatives and related compounds
#15Method for producing alpha-substituted cysteine or salt thereof or synthetic intermediate of alpha-substituted cysteine
#16Cysteine prodrugs
#17Therapeutic thiazolidinone compounds
#18Substituted N-acetyl-L-cysteine derivatives and related compounds
#19Deuterated Thiazolidinone Analogues as Agonists for Follicle Stimulating Hormone Receptor
#20Reactive oxygen species-based prodrugs
#21Compounds for modulating integrin CD11B/CD18
#22Compositions and methods for cytoprotection
#23Compounds for modulating integrin CD11b/CD18
#24THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
#25Compound
#26Compound
#27Novel Compounds 569
#28New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
#29Cytoskeletal active compounds, composition and use
#30Compounds for modulating integrin CD11b/CD18
#31METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG
#324-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY
#33CGRP receptor antagonists
#34THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF
#35Compositions and methods for cytoprotection
#36Pesticidal heterocycles
#37Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
#38Novel Haloalkylsulfonanilide Derivative, Herbicide, and Method of Use Thereof
#39Compounds 569
#40Compound
#41Cytoskeletal active compounds, composition and use
#42CGRP receptor antagonists
#43Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
#44Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
#45Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
#46Metasubstituted thiazolidinones, their manufacture and use as a drug
#47EP4 receptor agonist, compositions and methods thereof
#48Thiazolidinones, their production and use as pharmaceutical agents
#49Cytoskeletal active compounds, compositions and use
#50Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EPreceptor agonists in the treatment of glaucoma
#51Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
#52Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#53Pesticidal heterocycles
#54Novel heterocyclic compound and anti-inflamatory agent
#55Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione